Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
出版年份 2016 全文链接
标题
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
作者
关键词
-
出版物
Biomed Research International
Volume 2016, Issue -, Pages 1-12
出版商
Hindawi Limited
发表日期
2016-04-22
DOI
10.1155/2016/1752854
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
- (2015) Gregory A. Roth et al. CIRCULATION
- Osteoprotegerin in Cardiometabolic Disorders
- (2015) C. Pérez de Ciriza et al. International Journal of Endocrinology
- Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
- (2015) Wanchun Shi et al. BioScience Trends
- Elevated Osteoprotegerin Predicts Declining Renal Function in Elderly Women: A 10-Year Prospective Cohort Study
- (2014) Joshua R. Lewis et al. AMERICAN JOURNAL OF NEPHROLOGY
- Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation
- (2014) Paula Clancy et al. ATHEROSCLEROSIS
- Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification
- (2014) Carmen Pérez de Ciriza et al. CLINICAL BIOCHEMISTRY
- Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
- (2014) Stella Bernardi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model
- (2014) Veronica Tisato et al. PLoS One
- Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: A protector or culprit?
- (2014) Wen Cheng et al. VASCULAR PHARMACOLOGY
- Crosstalk between apoptosis, necrosis and autophagy
- (2013) Vassiliki Nikoletopoulou et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
- (2013) D. Gordin et al. DIABETES CARE
- TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
- (2013) Belinda A. Di Bartolo et al. PLoS One
- The role of osteoprotegerin in cardiovascular disease
- (2012) Martina Montagnana et al. ANNALS OF MEDICINE
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation
- (2012) Stella Bernardi et al. CLINICAL SCIENCE
- Osteoprotegerin, leptin and IL-6: Association with silent myocardial ischemia in type 2 diabetes mellitus
- (2012) Savas Guzel et al. Diabetes & Vascular Disease Research
- TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice
- (2012) Xiang Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
- (2012) Stella Bernardi et al. Recent Patents on Anti-Cancer Drug Discovery
- Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop
- (2011) Barbara Toffoli et al. ATHEROSCLEROSIS
- TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
- (2011) Victoria Watt et al. ATHEROSCLEROSIS
- Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin
- (2011) Michael Schoppet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
- (2011) Henrik Reinhard et al. Cardiovascular Diabetology
- Osteoprotegerin Predicts Progression of Chronic Heart Failure: Results From CORONA
- (2011) Thor Ueland et al. Circulation-Heart Failure
- TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice
- (2011) B. A. Di Bartolo et al. DIABETOLOGIA
- TRAIL shows potential cardioprotective activity
- (2011) Barbara Toffoli et al. INVESTIGATIONAL NEW DRUGS
- Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study
- (2011) A. VIK et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association of Osteoprotegerin With Aortic Stiffness in Patients With Symptomatic Peripheral Artery Disease and in Healthy Subjects
- (2010) M. Zagura et al. AMERICAN JOURNAL OF HYPERTENSION
- Biomarkers of the Osteoprotegerin Pathway
- (2010) Wolfgang Lieb et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction
- (2010) Paola Secchiero et al. ATHEROSCLEROSIS
- Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults
- (2010) Stefano Volpato et al. ATHEROSCLEROSIS
- Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
- (2010) Merlin C. Thomas et al. CIRCULATION RESEARCH
- Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
- (2010) Jong Suk Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
- (2010) Shreenidhi M. Venuraju et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease
- (2010) S. JONO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets
- (2010) Barbara Toffoli et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
- (2010) Ashish Upadhyay et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients
- (2010) S. Liabeuf et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events
- (2009) Anne G. Semb et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction
- (2009) Paola Secchiero et al. ATHEROSCLEROSIS
- Prognostic value of apoptosis markers in advanced heart failure patients
- (2009) A. Niessner et al. EUROPEAN HEART JOURNAL
- Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo
- (2009) Riccardo Candido et al. JOURNAL OF VASCULAR RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
- (2009) Paola Secchiero et al. PLoS One
- Osteoprotegerin released from the vascular wall by heparin mainly derives from vascular smooth muscle cells
- (2008) Mads Nybo et al. ATHEROSCLEROSIS
- Role of full-length osteoprotegerin in tumor cell biology
- (2008) G. Zauli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
- (2008) Sean Morony et al. CIRCULATION
- Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
- (2008) A. Jorsal et al. DIABETOLOGIA
- To kill a tumor cell: the potential of proapoptotic receptor agonists
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes
- (2008) Torbjørn Omland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interaction between Angiotensin II, Osteoprotegerin, and Peroxisome Proliferator-Activated Receptor-γ in Abdominal Aortic Aneurysm
- (2008) Corey S. Moran et al. JOURNAL OF VASCULAR RESEARCH
- Expression, regulation and function of trail in atherosclerosis
- (2007) Mary M. Kavurma et al. BIOCHEMICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now